J Clin Neurol.  2014 Oct;10(4):371-372. 10.3988/jcn.2014.10.4.371.

Does Hereditary Neuropathy with Liability to Pressure Palsy Predispose to Schwannomatosis?

Affiliations
  • 1Centre de Reference des Maladies Neuromusculaires et de la SLA, Centre Hospitalier Universitaire de La Timone, Marseille, France.
  • 2Service de Neurochirurgie, Hopital Nord, Marseille, France. fabrice.battaglia@ap-hm.fr

Abstract

No abstract available.


MeSH Terms

Paralysis*

Figure

  • Fig. 1 Magnetic resonance imaging of the lumbar spine (sagittal view). A: T2-weighted images showing a hypointense intradural lesion at the L2-L3 level (arrows). B: T1-weighted, gadolinium-enhanced images showing enhancement by this lesion (arrows).


Reference

1. Behse F, Buchthal F, Carlsen F, Knappeis GG. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain. 1972; 95:777–794.
Article
2. Gouider R, LeGuern E, Gugenheim M, Tardieu S, Maisonobe T, Léger JM, et al. Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology. 1995; 45:2018–2023.
Article
3. MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, et al. Diagnostic criteria for schwannomatosis. Neurology. 2005; 64:1838–1845.
Article
4. Heckmann JG, Dütsch M, Buslei R. Hereditary neuropathy with liability to pressure palsy combined with schwannomas of the median and medial plantar nerves. Muscle Nerve. 2007; 35:122–124.
Article
5. Ohyagi M, Sanjo N, Yokota T, Mizusawa H. Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. J Neurol. 2012; 259:977–979.
Article
6. Kwon JY, Chung KW, Park EK, Park SW, Choi BO. Charcot-Marie-Tooth 1A concurrent with schwannomas of the spinal cord and median nerve. J Korean Med Sci. 2009; 24:763–766.
Article
7. Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem. 1993; 268:10372–10379.
Article
8. D'Urso D, Schmalenbach C, Zoidl G, Prior R, Müller HW. Studies on the effects of altered PMP22 expression during myelination in vitro. J Neurosci Res. 1997; 48:31–42.
9. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet. 1997; 61:1293–1302.
Article
10. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007; 80:805–810.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr